
Michael Chang
Partner, Private Equity, Co-head of Healthcare
Antelliq is now the world’s leading animal intelligence group, providing world-class devices for animal identification, monitoring, and traceability. Its pioneering monitoring solutions deliver smart data products and services for the management and wellbeing of livestock, fish and pets. These solutions help veterinarians, farmers and pet owners gather critical data to improve management, health and well-being of livestock and pets and use digital technology to help respond to the growing demand for protein, food traceability and food safety.
As a truly innovative market leader with a clear vision and dynamic team, Antelliq has significant potential to continue leading the industry, as the use of intelligence, data and technology play an increasingly important role in animal health and care and on the back of strong trading, in December 2018, the Fund entered into an agreement with Merck to sell the company, which completed in March 2019.
Partner, Private Equity, Co-head of Healthcare
Partner, Private Equity, Co-head of Services
Director, Private Equity
KENILWORTH, N.J., April 1, 2019 – Merck [NYSE:MRK], known as MSD outside the United States and Canada, today announced the…
At BC, we provide our portfolio companies with the access and expertise to scale into leading global businesses. We are a partner for growth.